Main menu button

News

Equity Research Immunovia: Second clinical validation of next-generation test
19 Mar 2025
Equity Research Immunovia: Second clinical validation of next-generation test
Equity Research Immunovia
Equity Research InCoax: Financials strengthened after weak Q4 2024
19 Mar 2025
Equity Research InCoax: Financials strengthened after weak Q4 2024
Equity Research InCoax
Analyse Lokotech: Finansiering og store rammeavtaler sikret
13 Mar 2025
Analyse Lokotech: Finansiering og store rammeavtaler sikret
Equity Research Lokotech
Equity Research Lokotech: Financing and framework agreements secured
13 Mar 2025
Equity Research Lokotech: Financing and framework agreements secured
Equity Research Lokotech
Research update Biosergen: Continued success in India and cash injection
07 Mar 2025
Research update Biosergen: Continued success in India and cash injection
Equity Research Biosergen
Equity Research Svenska Aerogel, Q4 2024: Growing n.o customers and share issue in Q2
07 Mar 2025
Equity Research Svenska Aerogel, Q4 2024: Growing n.o customers and share issue in Q2
Equity Research Svenska Aerogel
Analyse Lokotech: sikrer 125 MNOK i en fortrinnsrettet emisjon
04 Mar 2025
Analyse Lokotech: sikrer 125 MNOK i en fortrinnsrettet emisjon
Equity Research Lokotech
Equity Research Lokotech: secures NOK 125 million through rights issue
04 Mar 2025
Equity Research Lokotech: secures NOK 125 million through rights issue
Equity Research Lokotech
Equity research, Zinzino Q4 2024: Growth weighs on margins in the short term
03 Mar 2025
Equity research, Zinzino Q4 2024: Growth weighs on margins in the short term
Equity Research Zinzino
Equity Research Enrad, Q4 2024: Full steam ahead with capital injection in March
03 Mar 2025
Equity Research Enrad, Q4 2024: Full steam ahead with capital injection in March
Equity Research Enrad
Video interview with CEO Dag Bergheim Pettersen, following the Q4 2024 report
28 Feb 2025
Video interview with CEO Dag Bergheim Pettersen, following the Q4 2024 report
Equity Research Zinzino
Equity Research Enrad, Q4 2024: Increased costs due to high pressure
28 Feb 2025
Equity Research Enrad, Q4 2024: Increased costs due to high pressure
Equity Research Enrad
Mrkt BUZZ InCoax Q4 2024: Delayed order lead to weak Q4 2024 results
27 Feb 2025
Mrkt BUZZ InCoax Q4 2024: Delayed order lead to weak Q4 2024 results
Equity Research InCoax
Equity Research Svenska Aerogel, Q4 2024: Higher than expected revenues and rights issue
27 Feb 2025
Equity Research Svenska Aerogel, Q4 2024: Higher than expected revenues and rights issue
Equity Research Svenska Aerogel
Equity research, Zinzino Q4 2024: First impression
27 Feb 2025
Equity research, Zinzino Q4 2024: First impression
Equity Research Zinzino
Equity Research Immunovia: Making headway with new cancer screening test
26 Feb 2025
Equity Research Immunovia: Making headway with new cancer screening test
Equity Research Immunovia
Equity research Teneo AI, Q4 2024: Teneo continues to deliver above expectations
25 Feb 2025
Equity research Teneo AI, Q4 2024: Teneo continues to deliver above expectations
Equity Research Teneo AI
Equity Research ALM Equity, Q4 2024: The market situation is about to improve
24 Feb 2025
Equity Research ALM Equity, Q4 2024: The market situation is about to improve
Equity Research ALM Equity
Equity research Viva Wine Group, Q4 2024: Positive growth momentum should continue
20 Feb 2025
Equity research Viva Wine Group, Q4 2024: Positive growth momentum should continue
Equity Research Viva Wine Group
Equity Research GIAB: Healthy core business risks reconstruction
20 Feb 2025
Equity Research GIAB: Healthy core business risks reconstruction
Equity Research GIAB